If AI Can Model Cells, Science Can Deliver Cures
The article discusses the potential of AI to revolutionize medical science by modeling cells and understanding complex biological processes. It emphasizes the need for collaboration among technology, research, and philanthropy to create a comprehensive data foundation for AI-accelerated biology. The author highlights the launch of the Virtual Biology Initiative, which aims to generate a massive open-source biological dataset to support this endeavor.
- ▪AI models have the potential to generate new proteins that target cancer cells and pathogens.
- ▪The Virtual Biology Initiative is being launched with a $100 million commitment to fund data generation.
- ▪Collaboration across the scientific community is essential to create a comprehensive database for cellular activity.
TIME — Top files mainly under news. We currently carry 213 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | TIME — Top |
| Canonical URL | https://time.com/article/2026/04/29/if-ai-can-model-cells-science-can-deliver-cures/ |
| Publication time | Wed, 29 Apr 2026 09:30:00 +0000 |
| Retrieval time | 2026-04-29T09:41:15.222Z |
| Last seen | 2026-04-29T09:41:15.222Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | zDax55ruJUtd |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
My journey into medicine started when I lost my grandpa to cancer. I remember him dropping me off at my sixth-grade classroom in the morning, and by the time I got home, he was gone. I bought an oncology textbook not long after that. Science had always been my favorite subject, and I thought it could help me find some answers.Years later, I was the doctor in the exam room, but I was still looking. The hospital where I worked was a national referral center for pediatric rare diseases, 95% of which have no cure. Every day, I was reminded how little medicine could explain about my patients’ conditions: the cellular dysfunction we could not see and the symptoms we could not explain.Each of us has felt some version of that grief and frustration. People we love are misdiagnosed.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TIME — Top.
Discussion
0 commentsMore from TIME — Top
